Zhou Q, Guo D, Shen T, Jiang H
Discov Oncol. 2024; 15(1):524.
PMID: 39365488
PMC: 11452370.
DOI: 10.1007/s12672-024-01406-1.
Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine J, Pilz M
Nat Commun. 2024; 15(1):2839.
PMID: 38565563
PMC: 10987549.
DOI: 10.1038/s41467-024-46540-0.
Li J, Ma S, Pei H, Jiang J, Zou Q, Lv Z
Heliyon. 2023; 9(11):e21329.
PMID: 37954355
PMC: 10637962.
DOI: 10.1016/j.heliyon.2023.e21329.
Tjernberg I, Lager M, Furset Jensen G, Eikeland R, Nyman D, Brudin L
PLoS One. 2023; 18(6):e0287586.
PMID: 37363901
PMC: 10292690.
DOI: 10.1371/journal.pone.0287586.
Cho W, Baek I, Kim S, Kim M, Kim T, Suh B
Immun Inflamm Dis. 2023; 11(3):e800.
PMID: 36988246
PMC: 10013136.
DOI: 10.1002/iid3.800.
Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer.
Li X, Wang R, Wang S, Wang L, Yu J
Front Immunol. 2022; 13:989968.
PMID: 36389757
PMC: 9647047.
DOI: 10.3389/fimmu.2022.989968.
The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer.
Kumar S, Prajapati K, Gupta S
Int J Mol Sci. 2022; 23(18).
PMID: 36142489
PMC: 9503623.
DOI: 10.3390/ijms231810577.
Integral membrane protein 2A enhances sensitivity to chemotherapy via notch signaling pathway in cervical cancer.
Li Y, Wang J, Gao C, Hu Q, Mao X
Bioengineered. 2021; 12(2):10183-10193.
PMID: 34872446
PMC: 8809943.
DOI: 10.1080/21655979.2021.2001218.
ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer.
Zhang R, Xu T, Xia Y, Wang Z, Li X, Chen W
Front Oncol. 2021; 10:581733.
PMID: 33680917
PMC: 7928367.
DOI: 10.3389/fonc.2020.581733.
Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer.
Dalangood S, Zhu Z, Ma Z, Li J, Zeng Q, Yan Y
Theranostics. 2020; 10(22):10078-10091.
PMID: 32929335
PMC: 7481430.
DOI: 10.7150/thno.48711.
Maternal atopy and offspring epigenome-wide methylation signature.
Danielewicz H, Gurgul A, Debinska A, Myszczyszyn G, Szmatola T, Myszkal A
Epigenetics. 2020; 16(6):629-641.
PMID: 32902349
PMC: 8143219.
DOI: 10.1080/15592294.2020.1814504.
Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts.
Dooley B, Verma A, Ding R, Yang H, Muthukumar T, Lubetzky M
Transplant Direct. 2020; 6(8):e588.
PMID: 32766436
PMC: 7377920.
DOI: 10.1097/TXD.0000000000001035.
Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction.
Zhou C, Wang M, Yang J, Xiong H, Wang Y, Tang J
Cell Commun Signal. 2019; 17(1):105.
PMID: 31438969
PMC: 6704577.
DOI: 10.1186/s12964-019-0422-7.
Structural characterization of the third scavenger receptor cysteine-rich domain of murine neurotrypsin.
Canciani A, Catucci G, Forneris F
Protein Sci. 2019; 28(4):746-755.
PMID: 30748049
PMC: 6423723.
DOI: 10.1002/pro.3587.
MicroRNA-146a Overexpression Impairs the Positive Selection during T Cell Development.
Li Z, Zhang S, Wan Y, Cai M, Wang W, Zhu Y
Front Immunol. 2018; 8:2006.
PMID: 29410664
PMC: 5787067.
DOI: 10.3389/fimmu.2017.02006.
Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
Davies S, Ryan J, OConnor P, Kenny E, Morris D, Baranov P
Adipocyte. 2017; 6(4):259-276.
PMID: 28872940
PMC: 5736245.
DOI: 10.1080/21623945.2017.1362510.
Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia.
Hou Q, Liao F, Zhang S, Zhang D, Zhang Y, Zhou X
Oncotarget. 2017; 8(22):36040-36053.
PMID: 28415601
PMC: 5482637.
DOI: 10.18632/oncotarget.16424.
The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase.
Namkoong S, Il Lee K, Lee J, Park R, Lee E, Jang I
Autophagy. 2015; 11(5):756-68.
PMID: 25951193
PMC: 4509440.
DOI: 10.1080/15548627.2015.1034412.